{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:51:50Z","timestamp":1747889510576,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Fund for Clinical Research of Wu Jieping Medical Foundation","award":["320.6750.18230"],"award-info":[{"award-number":["320.6750.18230"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02792-w","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:53:36Z","timestamp":1747860816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An immune-based predictive model for HBV clearance: validation in multicenter cohorts and mechanistic insights from in vivo studies"],"prefix":"10.1186","volume":"22","author":[{"given":"Rongzheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"1","key":"2792_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cld.2022.08.001","volume":"27","author":"A Robinson","year":"2023","unstructured":"Robinson A, Wong R, Gish RG. Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments. Clin Liver Dis. 2023;27(1):17\u201325. https:\/\/doi.org\/10.1016\/j.cld.2022.08.001.","journal-title":"Clin Liver Dis"},{"key":"2792_CR2","unstructured":"WHO. Hepatitis B Key facts. 2022. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"issue":"2","key":"2792_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11684-014-0331-5","volume":"8","author":"R Yu","year":"2014","unstructured":"Yu R, Fan R, Hou J. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China. Front Med. 2014;8(2):135\u201344. https:\/\/doi.org\/10.1007\/s11684-014-0331-5.","journal-title":"Front Med"},{"issue":"2","key":"2792_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1055\/s-2006-939753","volume":"26","author":"HL Chan","year":"2006","unstructured":"Chan HL, Sung JJ. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis. 2006;26(2):153\u201361. https:\/\/doi.org\/10.1055\/s-2006-939753.","journal-title":"Semin Liver Dis"},{"issue":"7","key":"2792_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2802","volume":"10","author":"BT Rouse","year":"2010","unstructured":"Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol. 2010;10(7):514\u201326. https:\/\/doi.org\/10.1038\/nri2802.","journal-title":"Nat Rev Immunol"},{"key":"2792_CR6","doi-asserted-by":"publisher","first-page":"1075916","DOI":"10.3389\/fimmu.2022.1075916","volume":"13","author":"JR Zheng","year":"2022","unstructured":"Zheng JR, Wang ZL, Feng B. Hepatitis B functional cure and immune response. Front Immunol. 2022;13:1075916. https:\/\/doi.org\/10.3389\/fimmu.2022.1075916.","journal-title":"Front Immunol"},{"issue":"37","key":"2792_CR7","doi-asserted-by":"publisher","first-page":"13293","DOI":"10.3748\/wjg.v20.i37.13293","volume":"20","author":"CR You","year":"2014","unstructured":"You CR, Lee SW, Jang JW, Yoon SK. Update on hepatitis B virus infection. World J Gastroenterol. 2014;20(37):13293\u2013305. https:\/\/doi.org\/10.3748\/wjg.v20.i37.13293.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2792_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","volume":"154","author":"X Wang","year":"2018","unstructured":"Wang X, Dong Q, Li Q, et al. Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients. Gastroenterology. 2018;154(8):2222\u201336. https:\/\/doi.org\/10.1053\/j.gastro.2018.03.021.","journal-title":"Gastroenterology"},{"issue":"5","key":"2792_CR9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3390\/cells10051114+","volume":"10","author":"SI Buschow","year":"2021","unstructured":"Buschow SI, Jansen DTSL. CD4 T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy. Cells. 2021;10(5):1114. https:\/\/doi.org\/10.3390\/cells10051114+.","journal-title":"Cells"},{"issue":"4","key":"2792_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.it.2017.02.003","volume":"38","author":"A Kallies","year":"2017","unstructured":"Kallies A, Good-Jacobson KL. Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System. Trends Immunol. 2017;38(4):287\u201397. https:\/\/doi.org\/10.1016\/j.it.2017.02.003.","journal-title":"Trends Immunol"},{"issue":"3","key":"2792_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","volume":"31","author":"D Yu","year":"2009","unstructured":"Yu D, Rao S, Tsai LM, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457\u201368. https:\/\/doi.org\/10.1016\/j.immuni.2009.07.002.","journal-title":"Immunity"},{"issue":"11","key":"2792_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nri3536","volume":"13","author":"V Lazarevic","year":"2013","unstructured":"Lazarevic V, Glimcher LH, Lord GM. T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol. 2013;13(11):777\u201389. https:\/\/doi.org\/10.1038\/nri3536.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2792_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/intimm\/dxt063","volume":"26","author":"Y Tanriver","year":"2014","unstructured":"Tanriver Y, Diefenbach A. Transcription factors controlling development and function of innate lymphoid cells. Int Immunol. 2014;26(3):119\u201328. https:\/\/doi.org\/10.1093\/intimm\/dxt063.","journal-title":"Int Immunol"},{"key":"2792_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.805625","volume":"8","author":"S Zhong","year":"2021","unstructured":"Zhong S, Zhang T, Tang L, Li Y. Cytokines and Chemokines in HBV Infection. Front Mol Biosci. 2021;8: 805625. https:\/\/doi.org\/10.3389\/fmolb.2021.805625.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"2792_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog. 2009;5(2): e1000313. https:\/\/doi.org\/10.1371\/journal.ppat.1000313.","journal-title":"PLoS Pathog"},{"issue":"6","key":"2792_CR16","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh B, Schraut W, Gerlach T, et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology. 2010;52(6):1934\u201347. https:\/\/doi.org\/10.1002\/hep.23936.","journal-title":"Hepatology"},{"key":"2792_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/JHC.S390858","volume":"9","author":"Z Hu","year":"2022","unstructured":"Hu Z, Yuan Y, Hu Z, et al. Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers. J Hepatocell Carcinoma. 2022;9:1403\u201313. https:\/\/doi.org\/10.2147\/JHC.S390858.","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"2792_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-020-01595-w","volume":"18","author":"G Xie","year":"2020","unstructured":"Xie G, Wang X, Wei R, et al. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med. 2020;18(1):144. https:\/\/doi.org\/10.1186\/s12916-020-01595-w.","journal-title":"BMC Med"},{"issue":"1","key":"2792_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12876-020-01191-5","volume":"20","author":"Y Hou","year":"2020","unstructured":"Hou Y, Zhang Q, Gao F, et al. Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure. BMC Gastroenterol. 2020;20(1):75. https:\/\/doi.org\/10.1186\/s12876-020-01191-5.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"2792_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bpg.2017.04.014","volume":"31","author":"M Dandri","year":"2017","unstructured":"Dandri M, Petersen J. Animal models of HBV infection. Best Pract Res Clin Gastroenterol. 2017;31(3):273\u20139. https:\/\/doi.org\/10.1016\/j.bpg.2017.04.014.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"47","key":"2792_CR21","doi-asserted-by":"publisher","first-page":"17862","DOI":"10.1073\/pnas.0608578103","volume":"103","author":"LR Huang","year":"2006","unstructured":"Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006;103(47):17862\u20137. https:\/\/doi.org\/10.1073\/pnas.0608578103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2792_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12985-017-0874-6","volume":"14","author":"L Li","year":"2017","unstructured":"Li L, Li S, Zhou Y, et al. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model. Virol J. 2017;14(1):205. https:\/\/doi.org\/10.1186\/s12985-017-0874-6.","journal-title":"Virol J"},{"issue":"1","key":"2792_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12985-018-1002-y","volume":"15","author":"X Wang","year":"2018","unstructured":"Wang X, Zhu J, Zhang Y, et al. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model. Virol J. 2018;15(1):89. https:\/\/doi.org\/10.1186\/s12985-018-1002-y.","journal-title":"Virol J"},{"key":"2792_CR24","doi-asserted-by":"publisher","first-page":"9471520","DOI":"10.1155\/2023\/9471520","volume":"2023","author":"R Zhang","year":"2023","unstructured":"Zhang R, Xia Y, Dong J, et al. Comprehensive Analysis of m7G-Related Genes and Chronic Hepatitis B: Diagnostic Markers, Immune Microenvironment Regulation. Disease Progression J Immunol Res. 2023;2023:9471520. https:\/\/doi.org\/10.1155\/2023\/9471520.","journal-title":"Disease Progression J Immunol Res"},{"issue":"4","key":"2792_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529\u201338. https:\/\/doi.org\/10.1016\/j.jhep.2006.05.013.","journal-title":"J Hepatol"},{"issue":"30","key":"2792_CR26","doi-asserted-by":"publisher","first-page":"10395","DOI":"10.3748\/wjg.v20.i30.10395","volume":"20","author":"CM Croagh","year":"2014","unstructured":"Croagh CM, Lubel JS. Natural history of chronic hepatitis B: phases in a complex relationship. World J Gastroenterol. 2014;20(30):10395\u2013404. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10395.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2792_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/s0092-8674(00)80240-8","volume":"89","author":"W Zheng","year":"1997","unstructured":"Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997;89(4):587\u201396. https:\/\/doi.org\/10.1016\/s0092-8674(00)80240-8.","journal-title":"Cell"},{"issue":"11","key":"2792_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni1128","volume":"5","author":"J Zhu","year":"2004","unstructured":"Zhu J, Min B, Hu-Li J, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5(11):1157\u201365. https:\/\/doi.org\/10.1038\/ni1128.","journal-title":"Nat Immunol"},{"issue":"7","key":"2792_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/infdis\/jis011","volume":"205","author":"M Zhang","year":"2012","unstructured":"Zhang M, Zhou J, Zhao T, et al. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states. J Infect Dis. 2012;205(7):1111\u201320. https:\/\/doi.org\/10.1093\/infdis\/jis011.","journal-title":"J Infect Dis"},{"issue":"3","key":"2792_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep.25765","volume":"56","author":"L Stross","year":"2012","unstructured":"Stross L, G\u00fcnther J, Gasteiger G, et al. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice. Hepatology. 2012;56(3):873\u201383. https:\/\/doi.org\/10.1002\/hep.25765.","journal-title":"Hepatology"},{"issue":"1","key":"2792_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","volume":"150","author":"Y Xia","year":"2016","unstructured":"Xia Y, Stadler D, Lucifora J, et al. Interferon-\u03b3 and Tumor Necrosis Factor-\u03b1 Produced by T Cells Reduce the HBV Persistence Form, cccDNA. Without Cytolysis Gastroenterology. 2016;150(1):194\u2013205. https:\/\/doi.org\/10.1053\/j.gastro.2015.09.026.","journal-title":"Without Cytolysis Gastroenterology"},{"issue":"5","key":"2792_CR32","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2016.04.022","volume":"44","author":"J Attanasio","year":"2016","unstructured":"Attanasio J, Wherry EJ. Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity. 2016;44(5):1052\u201368. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.022.","journal-title":"Immunity"},{"key":"2792_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fphar.2017.00591","volume":"8","author":"M Huang","year":"2017","unstructured":"Huang M, Sun R, Huang Q, Tian Z. Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases. Front Pharmacol. 2017;8:591. https:\/\/doi.org\/10.3389\/fphar.2017.00591.","journal-title":"Front Pharmacol"},{"issue":"19","key":"2792_CR34","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.1128\/JVI.00867-09","volume":"83","author":"S Asabe","year":"2009","unstructured":"Asabe S, Wieland SF, Chattopadhyay PK, et al. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol. 2009;83(19):9652\u201362. https:\/\/doi.org\/10.1128\/JVI.00867-09.","journal-title":"J Virol"},{"issue":"2","key":"2792_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/v9020035","volume":"9","author":"W Wu","year":"2017","unstructured":"Wu W, Liu Y, Lin Y, et al. PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB\/c Mouse Model. Viruses. 2017;9(2):35. https:\/\/doi.org\/10.3390\/v9020035.","journal-title":"Viruses"},{"issue":"44","key":"2792_CR36","doi-asserted-by":"publisher","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","volume":"288","author":"K Watashi","year":"2013","unstructured":"Watashi K, Liang G, Iwamoto M, Marusawa H, Uchida N, Daito T, Kitamura K, Muramatsu M, Ohashi H, Kiyohara T, Suzuki R, Li J, Tong S, Tanaka Y, Murata K, Aizaki H, Wakita T. Interleukin-1 and tumor necrosis factor-\u03b1 trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID). J Biol Chem. 2013;288(44):31715\u201327. https:\/\/doi.org\/10.1074\/jbc.M113.501122.","journal-title":"J Biol Chem"},{"issue":"14","key":"2792_CR37","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1128\/JVI.00554-07","volume":"81","author":"R Puro","year":"2007","unstructured":"Puro R, Schneider RJ. Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol. 2007;81(14):7351\u201362. https:\/\/doi.org\/10.1128\/JVI.00554-07.","journal-title":"J Virol"},{"issue":"2","key":"2792_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2015.09.012","volume":"64","author":"YK Park","year":"2016","unstructured":"Park YK, Park ES, Kim DH, Ahn SH, Park SH, Lee AR, Park S, Kang HS, Lee JH, Kim JM, Lee SK, Lim KH, Isorce N, Tong S, Zoulim F, Kim KH. Cleaved c-FLIP mediates the antiviral effect of TNF-\u03b1 against hepatitis B virus by dysregulating hepatocyte nuclear factors. J Hepatol. 2016;64(2):268\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2015.09.012.","journal-title":"J Hepatol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02792-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T20:53:38Z","timestamp":1747860818000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02792-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2792"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02792-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research involving human participants in this study was approved by the Ethics Committee of Harbin Medical University, approval number KY27-118, in compliance with the Helsinki Declaration, and written informed consent was obtained from all participants. All experiments involving animal use were performed in accordance with the Ethics Committee of Harbin Medical University with approval number SYDW2010-144, and were conducted in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}